Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Neuroepithelial

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,951 public trials 642 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Completed

Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

NCT00411619

Conditions: Astrocytoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +25 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Completed

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

NCT00540176

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: University of Alberta Hospital Edmonton, Alberta, Canada

View Trial Details

Completed

Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma

NCT00098865

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Pediatric, Neoplasms, +12 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

NCT00528684

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

The Ohio State University Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Center Columbus, Ohio, United States

View Trial Details

Completed

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

NCT00357500

Conditions: Central Nervous System Neoplasms, Central Nervous System Tumor, Pediatric, Hematologic Diseases, +23 more
Locations: Connecticut Children's Medical Center Hartford, Connecticut, United States

Miami Children's Hospital Miami, Florida, United States

Children's Memorial Hospital - Chicago Chicago, Illinois, United States

Maine Medical Center Research Institute Scarborough, Maine, United States

View Trial Details

Completed

Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma

NCT00311584

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States

Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Southern California Permanente Medical Group Downey, California, United States

View all 128 locations

View Trial Details

Completed

Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors

NCT00618813

Conditions: Ewing Sarcoma of Bone, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Neoplasms, +8 more
Locations: Children's Oncology Group Monrovia, California, United States

View Trial Details

Completed

Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma

NCT00960492

Conditions: Astrocytoma, Giant Cell Glioblastoma, Glioblastoma, +9 more
Locations: UCLA Los Angeles, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Henry Ford Health System Detroit, Michigan, United States

Beth Israel Medical Center New York, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details